What to confirm across a peptide formulary
Do not assume a single peptide price applies across your formulary. Contact Wells directly before launching a peptide program and ask for per-Rx cost estimates on each peptide you actually order — BPC-157, sermorelin, NAD+, and whatever else sits in your protocols — because costs differ meaningfully by molecule. Confirm the strength and vial size for each, since peptide dosing varies and a wrong vial assumption distorts your per-dose cost. Ask whether low-volume peptides carry higher per-unit pricing or minimums, and whether adding a peptide to your protocols later requires a new estimate. For protocols that stack multiple peptides per patient, confirm the combined cost so you can price the stack accurately, not just the individual components.
The practical risk with post-placement peptide pricing is staleness. Once you have your initial per-Rx costs for launch-day SKUs, any peptide added later surfaces its cost only after the first order places. Keep written per-Rx cost references current for every peptide your margin depends on — especially for newer additions to your formulary.